Skip to content. Skip to navigation
Sections
Personal tools
You are here: Home Events OOS Investigations in a GMP Environment (2 day)
Navigation
Log in


Forgot your password?
New user?
Site Search
 
Search only the current folder (and sub-folders)
 
Document Actions

OOS Investigations in a GMP Environment (2 day)

Type Course
Language English
Date October 18, 2011 to
October 19, 2011
Venue Window Conference Venue
13 Windsor Street
Islington, London N1 8QG
GB
Chemistry Specialties
  • biotechnology
  • medicinal and pharmaceutical chemistry
Chemistry Techniques
  • other
Contact Judy Callanan
PharmaTraining Limited
BioCity, Pennyfoot Street
Nottingham, NG1 1GF
GB
44 (0) 115 9124249
44 (0) 207 6813582
judy@pharma-training-courses.com
Add event to calendar vCal (Windows, Linux)
iCal (Mac OS X)
by Judy Callanan last modified 09-12-11 03:05 AM

This course is designed to provide essential training for conducting Out of Specification (OOS) investigations in a GMP environment. A background discussion of the associated GMP documentation required to support the OOS investigation is included but the majority of time is spent detailing the who, what, when, how and why of the investigation, determining the extent of the investigation during Phase I and Phase II, documenting findings determining root causes and assigning corrective and preventative actions. This course is presented in a dynamic environment created by a power point presentation, interactive exercises, case studies and group discussion. Participants are welcome to bring their own examples for group discussion sessions. The workshop emphasizes practical issues such as: • The importance of good quality support systems • FDA audit observations and how they could have been avoided • Case studies • A detailed guide to conducting Phase 1 and Phase II of the investigation • Reporting and evaluating passing and failing results The course provides ample opportunities for group discussions, case studies and exercises. It enables participants to gain the skills and knowledge necessary to meet current regulatory expectations. The course material is based on the FDA guideline “Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production”, October 2006

Speakers

Dr Pauline McGregor Twenty years in the pharmaceutical industry has included working for pharmaceutical companies and Contract Testing Laboratories in Canada and the UK.

More information about this event…

« May 2013 »
Su Mo Tu We Th Fr Sa
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
Sponsors
Web Search
 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: